Pasithea Therapeutics Corp. (KTTA) stock
KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.43−0.07 (-13.14%)
Close on Nov 17, 2026Market cap $14.51MP/E –Yield –
Pasithea Therapeutics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Pasithea Therapeutics's profit margin for the twelve months ending Dec 31, 2022 was -2864.3%. For fiscal 2022 it was -2864.3%, against -14430.5% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -2864.3% | +11566.2 |
| FY2021 | Dec 31, 2021 | -14430.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -2126.1% | – |
| Q3 FY2022 | Sep 30, 2022 | -2097.9% | – |
| Q2 FY2022 | Jun 30, 2022 | -19574.4% | – |
| Q1 FY2022 | Mar 31, 2022 | -11526.1% | – |
See a number that looks wrong?